• All new members please introduce your self here and welcome to the board:
    http://www.professionalmuscle.com/forums/showthread.php?t=259
Buy Needles And Syringes With No Prescription
M4B Store Banner
muscleshop
Riptropin Store banner
Generation X Bodybuilding Forum
Buy Needles And Syringes With No Prescription
Buy Needles And Syringes With No Prescription
Mysupps Store Banner
IP Gear Store Banner
PM-Ace-Labs
Ganabol Store Banner
Spend $100 and get bonus needles free at sterile syringes
Professional Muscle Store open now
sunrise2
PHARMAHGH1
kinglab
ganabol2
Professional Muscle Store open now
over 5000 supplements on sale at professional muscle store
advertise1
granabolic1
napsgear-210x65
finestgears
over 5000 supplements on sale at professional muscle store
over 5000 supplements on sale at professional muscle store
ashp210
UGFREAK-banner-PM
advertise1
advertise1
over 5000 supplements on sale at professional muscle store
over 5000 supplements on sale at professional muscle store
over 5000 supplements on sale at professional muscle store
over 5000 supplements on sale at professional muscle store
over 5000 supplements on sale at professional muscle store
over 5000 supplements on sale at professional muscle store
over 5000 supplements on sale at professional muscle store

Raising HDL with Toremifine?

Shelby

IFBB PRO / Double Featured Member/Kilo Klub
IFBB PROS
Kilo Klub Member
Registered
Joined
Oct 3, 2005
Messages
6,572
A lot of guys take nolvadex to raise HDL.. but it looks like Toremifine might be a better choice.

Anyone have experience / input?

**broken link removed**
 

stankyleg

Member
Registered
Joined
Oct 4, 2010
Messages
337
I dont know about how it effects hdl, but makes my boys nice and full :)
 

dragonfire101

Well-known member
Kilo Klub Member
Registered
Joined
Sep 25, 2002
Messages
5,879
Effect of toremifene in lowering total cholesterol, LDL, and triglycerides and raisin

Effect of toremifene in lowering total cholesterol, LDL, and triglycerides and raising HDL in prostate cancer patients on androgen deprivation therapy.


Sub-category:
Prostate Cancer

Category:
Genitourinary Cancer

Meeting:
2007 ASCO Annual Meeting

Session Type and Session Title:
General Poster Session, Genitourinary Cancer

Abstract No:
5124

Citation:
Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No. 18S (June 20 Supplement), 2007: 5124

Author(s):
M. Smith, F. Chu, J. Forrest, S. B. Malkowicz, D. Price, P. Sieber, K. G. Barnette, D. Rodriguez, M. S. Steiner

Abstract:

Introduction: Androgen deprivation therapy (ADT) is the standard treatment for men with advanced prostate cancer. ADT has been shown to detrimentally affect lipids (average 9% increase in total cholesterol and 26% increase in triglycerides) and is associated with increased risk of coronary heart disease and myocardial infarction. Toremifene, a selective estrogen receptor modulator (SERM), improves bone mineral density and lipid profiles in women. An ongoing phase III trial will assess the safety and efficacy of toremifene in treating multiple side effects of ADT including osteoporosis, hot flashes, gynecomastia and lipid profiles. Given the emerging recognition of increased cardiovascular risk during ADT, an interim analysis was conducted to assess the effects of toremifene on lipid profiles in the ongoing phase III study. Methods: 1,392 men = 50 years old with histologically documented prostate cancer and receiving ADT were randomized to toremifene (80 mg/day) or placebo. An interim analysis evaluated changes in lipids from baseline to month 12 in the first 197 subjects to complete one-year follow up. The outcomes measured in this interim analysis were total cholesterol, LDL cholesterol, triglycerides, total cholesterol/HDL ratio, and HDL cholesterol. Results: Compared to treatment with placebo, toremifene decreased total cholesterol (7.1%; p=0.001 for between group comparison), LDL cholesterol (9.0%; p=0.003), and triglycerides (20.1%; p=0.009) levels, and the total cholesterol/HDL ratio (11.7%; p<0.001). Toremifene also significantly increased HDL levels (5.4%; p=0.018) compared to placebo. The effects of toremifene were observed in both statin users and nonusers. Conclusions: Toremifene decreases total cholesterol, LDL cholesterol, and triglycerides and increases HDL cholesterol in men receiving ADT for advanced prostate cancer compared to placebo. Conclusions regarding the clinical significance of these observations will be based on the full cohort of patients at the conclusion of the trial.
 

mikevegas

Active member
Registered
Joined
Jan 7, 2011
Messages
416
I've used Torem with great success for PCT. Don't know how it effected my HDL, but put test count into orbit with no physical sides that I noticed.
 

EDED

Banned
Joined
Jan 31, 2009
Messages
987
postmenopause and intentional andropause (ADT)

**broken link removed**

wonder how we gear users who are APT (androgen plenty therapy) lol would be like on this type of study?

totally different situation here right?

although agonism of ER at certain other places can be beneficial to HDL but not sure by how much on gear users on multiple things (DHT based gear to AI here and there etc)

anybody else with lab results on torem and on gear?

of course off gear and torem (IME) gave great bloodwork tahts a no brainer.

Effect of toremifene in lowering total cholesterol, LDL, and triglycerides and raising HDL in prostate cancer patients on androgen deprivation therapy.


Sub-category:
Prostate Cancer

Category:
Genitourinary Cancer

Meeting:
2007 ASCO Annual Meeting

Session Type and Session Title:
General Poster Session, Genitourinary Cancer

Abstract No:
5124

Citation:
Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No. 18S (June 20 Supplement), 2007: 5124

Author(s):
M. Smith, F. Chu, J. Forrest, S. B. Malkowicz, D. Price, P. Sieber, K. G. Barnette, D. Rodriguez, M. S. Steiner

Abstract:

Introduction: Androgen deprivation therapy (ADT) is the standard treatment for men with advanced prostate cancer. ADT has been shown to detrimentally affect lipids (average 9% increase in total cholesterol and 26% increase in triglycerides) and is associated with increased risk of coronary heart disease and myocardial infarction. Toremifene, a selective estrogen receptor modulator (SERM), improves bone mineral density and lipid profiles in women. An ongoing phase III trial will assess the safety and efficacy of toremifene in treating multiple side effects of ADT including osteoporosis, hot flashes, gynecomastia and lipid profiles. Given the emerging recognition of increased cardiovascular risk during ADT, an interim analysis was conducted to assess the effects of toremifene on lipid profiles in the ongoing phase III study. Methods: 1,392 men = 50 years old with histologically documented prostate cancer and receiving ADT were randomized to toremifene (80 mg/day) or placebo. An interim analysis evaluated changes in lipids from baseline to month 12 in the first 197 subjects to complete one-year follow up. The outcomes measured in this interim analysis were total cholesterol, LDL cholesterol, triglycerides, total cholesterol/HDL ratio, and HDL cholesterol. Results: Compared to treatment with placebo, toremifene decreased total cholesterol (7.1%; p=0.001 for between group comparison), LDL cholesterol (9.0%; p=0.003), and triglycerides (20.1%; p=0.009) levels, and the total cholesterol/HDL ratio (11.7%; p<0.001). Toremifene also significantly increased HDL levels (5.4%; p=0.018) compared to placebo. The effects of toremifene were observed in both statin users and nonusers. Conclusions: Toremifene decreases total cholesterol, LDL cholesterol, and triglycerides and increases HDL cholesterol in men receiving ADT for advanced prostate cancer compared to placebo. Conclusions regarding the clinical significance of these observations will be based on the full cohort of patients at the conclusion of the trial.
 

dragonfire101

Well-known member
Kilo Klub Member
Registered
Joined
Sep 25, 2002
Messages
5,879
ya i couldn't find if the cohorts were maybe going to be NOT on androgen deprivation or a final study anywhere.

postmenopause and intentional andropause (ADT)

**broken link removed**

wonder how we gear users who are APT (androgen plenty therapy) lol would be like on this type of study?

totally different situation here right?

although agonism of ER at certain other places can be beneficial to HDL but not sure by how much on gear users on multiple things (DHT based gear to AI here and there etc)

anybody else with lab results on torem and on gear?

of course off gear and torem (IME) gave great bloodwork tahts a no brainer.
 

Staff online

  • pesty4077
    Moderator/ Featured Member / Kilo Klub

Forum statistics

Total page views
533,188,592
Threads
130,730
Messages
2,617,178
Members
158,361
Latest member
Getbig68
NapsGear
HGH Power Store email banner
Leader Powder Store email banner
Prowrist straps store banner
coach
FLASHING-BOTTOM-BANNER-210x131
raws
Savage Labs Store email
Syntherol Site Enhancing Oil Synthol
AQ3 email Banner
pomps
rawhormone
ezgif-com-resize-2-1
MA Research Chem store banner
MA Supps Store Banner
thc
Keytech banner
musclechem
Godbullraw-bottom-banner
Injection Instructions for beginners
Knight Labs store email banner
ODINBanner-PM1
ashp131
Advertise Here
Top